amlodipine has been researched along with losartan potassium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Danielson, BG; Hägg, A; Linde, T; Mörlin, C; Sandhagen, B | 1 |
| Bilen, H; Cetinkaya, R; Keles, S; Odabas, AR; Selcuk, Y | 1 |
| Canetta, PA; D'Agati, VD; Dahl, K; Radhakrishnan, J | 1 |
2 trial(s) available for amlodipine and losartan potassium
| Article | Year |
|---|---|
Decreased blood viscosity and serum levels of erythropoietin after anti-hypertensive treatment with amlodipine or metoprolol: results of a cross-over study.
Topics: Adult; Aged; Amlodipine; Blood Cell Count; Blood Chemical Analysis; Blood Viscosity; Cross-Over Studies; Erythropoietin; Female; Hemodynamics; Humans; Hypertension; Male; Metoprolol; Middle Aged | 1996 |
The effect of high dose losartan on erythropoietin resistance in patients undergoing haemodialysis.
Topics: Adult; Amlodipine; Anemia; Angiotensin Receptor Antagonists; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Resistance; Erythropoietin; Female; Humans; Hypertension; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2003 |
2 other study(ies) available for amlodipine and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A 56-year-old woman with sarcoidosis and acute renal failure.
Topics: Acute Kidney Injury; Amlodipine; Epoetin Alfa; Erythropoietin; Female; Fibrosis; Humans; Inflammation; Middle Aged; Prednisone; Recombinant Proteins; Sarcoidosis; Treatment Outcome | 2008 |